Achievement Laboratory of Liver Research

Publications

Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis.
Journal
Cell Metabolism
Vol
VOLUME 30, ISSUE 5
Page
P877-889
Author
Won-Mook Choi, Hee-Hoon Kim, Myung-Ho Kim, Resat Cinar, Hyon-Seung Yi, Hyuk Soo Eun, Seok-Hwan Kim, Young Jae Choi, Young-Sun Lee, So Yeon Kim, Wonhyo Seo, Jun-Hee Lee, Young-Ri Shim,...,Bin Gao, Won Kim, Sang Kyum Kim, George Kunos and Won-Il Jeong
Year
2019
Date
Nov 29, 2019

Activation of hepatocyte cannabinoid receptor-1 (CB1R) by hepatic stellate cell (HSC)-derived 2-arachidonoylglycerol (2-AG) drives de novo lipogenesis in alcoholic liver disease (ALD). How alcohol stimulates 2-AG production in HSCs is unknown. Here, we report that chronic alcohol consumption induced hepatic cysteine deficiency and subsequent glutathione depletion by impaired transsulfuration pathway. A compensatory increase in hepatic cystine-glutamate anti-porter xCT boosted extracellular glutamate levels coupled to cystine uptake both in mice and in patients with ALD. Alcohol also induced the selective expression of metabotropic glutamate receptor-5 (mGluR5) in HSCs where mGluR5 activation stimulated 2-AG production. Consistently, genetic or pharmacologic inhibition of mGluR5 or xCT attenuated alcoholic steatosis in mice via the suppression of 2-AG production and subsequent CB1R-mediated de novo lipogenesis. We conclude that a bidirectional signaling operates at a metabolic synapse between hepatocytes and HSCs through xCT-mediated glutamate-mGluR5 signaling to produce 2-AG, which induces CB1R-mediated alcoholic steatosis.


Cell Metabolism 30, 877–889 November 5, 2019